1. Home
  2. PRE

as of 12-15-2025 3:30pm EST

$14.60
$0.12
-0.82%
Stocks Industrials Biotechnology: Laboratory Analytical Instruments Nasdaq

Prenetics Global Ltd is a health sciences company dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, a U.S. sports distribution company. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.

Chart Type:
Time Range:
Founded: 2014 Country:
Hong Kong
Hong Kong
Employees: N/A City: N/A
Market Cap: 131.3M IPO Year: N/A
Target Price: $32.00 AVG Volume (30 days): 137.5K
Analyst Decision: Buy Number of Analysts: 1
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -3.52 EPS Growth: N/A
52 Week Low/High: $3.10 - $17.99 Next Earning Date: 11-10-2025
Revenue: $77,079,000 Revenue Growth: 201.54%
Revenue Growth (this year): 219.28% Revenue Growth (next year): 124.38%

AI-Powered PRE Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold
Model Accuracy: 67.59%
67.59%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Latest Prenetics Global Limited News

PRE Breaking Stock News: Dive into PRE Ticker-Specific Updates for Smart Investing

All PRE News

Share on Social Networks: